Christopher Hallam (GDPO) argues for increased support toward heroin-assisted treatment (HAT) by national governments and international bodies, including the INCB.
SSDP considers that the 'drugs cost lives' narrative, although well-meaning, is stigmatising and harmful, and fuels damaging approaches based on prohibition, punishment and criminalisation.
As we prepare for the global launch, IDPC, ENPUD and EHRA invite their members and other allies involved in drug policy advocacy to come and learn more about the Index.
ISSDP hosts a webinar to equip drug policy scholars with the skills and know-how to successfully publish peer-reviewed articles in drug policy relevant journals.
On July 21, we take the time to remember people whose lives were unjustly cut short due to the criminalisation and stigmatisation of people who use drugs.
The Expert Committee will consider whether information presented during a critical review may justify the scheduling or a change in the scheduling of the substance in the 1961 or 1971 Conventions.
The conversation will highlight key takeaways from the report as well as shed light on the burning issues that structured the Session’s debates, achievements and missed opportunities in this year’s adopted resolutions, and outlooks for civil society participation in the coming years.
The 64th session of the CND was marked by the increase in prominence of health and human rights narratives, the proceedings' 'hybrid format' and a welcome long-overdue shift in the US stance on harm reduction.
As long as UNODC continues to carefully and deliberately hold back from mentioning the harmful impact of states’ own drug policies, we cannot trust the agency to communicate all the facts.
The criminalisation of drugs affects sex workers more than any other demographic; as such, support for sex workers should be an important consideration in the reform movement.
As we prepare for the global launch, IDPC and WHRIN invite their members and other allies involved in drug policy advocacy to come and learn more about the Global Drug Policy Index.
As we prepare for the global launch, IDPC and WHRIN invite their members and other allies involved in drug policy advocacy to come and learn more about the Global Drug Policy Index.
